Gsk Share Discussion Threads

[estienne] 28/11/2024 15:28

Took advantage of the dip this afternoon and decided to increase my holding a bit. I can't see this not doing well and the dividend is good

[tradermichael] 27/11/2024 11:25

And there's more ......

GSK plc (LSE/NYSE: GSK) today announced that the European Medicine Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended for use a single-vial, fully liquid presentation of Menveo (Meningococcal Group A, C, W-135 and Y conjugate vaccine, MenACWY vaccine) to help protect against invasive meningococcal disease (IMD) caused by bacterial groups A, C, W, and Y.

[beergut] 26/11/2024 15:47

I assume we are talking about the US listing share price

[tradermichael] 26/11/2024 14:59

I preferred the 2610p ..........;0)

[dplewis1] 26/11/2024 11:16

Bernstein cuts target price to 2355p from 2610p

[cafc69] 26/11/2024 10:40

That's what I thought , but no impact on today

[hatfullofsky] 25/11/2024 20:59

Nice late trades

[tradermichael] 25/11/2024 08:26

Blenrep combinations accepted for review by the US FDA for the treatment of relapsed/refractory multiple myeloma

· Regulatory submission supported by phase III head-to-head DREAMM-7 and DREAMM-8 trials showing statistically significant efficacy, including overall survival in DREAMM-7

· If approved, Blenrep (belantamab mafodotin) in combinations with BorDex (BVd) and PomDex (BPd) could redefine multiple myeloma treatment at or after first relapse

· Sixth major regulatory filing acceptance this year for belantamab mafodotin combinations in this indication

[jubberjim] 22/11/2024 11:11

No rush await the inevitable dip.

[tradermichael] 22/11/2024 08:38

More good news ....

Arexvy approval expanded to adults aged 50-59 at increased risk of severe RSV disease in Japan


· First RSV vaccine approved in Japan to help protect 50-59 year olds at increased risk due to certain underlying health conditions

· RSV infections can exacerbate these underlying health conditions and lead to severe outcomes, such as pneumonia, hospitalisation and death.

· 35 countries, including the US, have expanded approval for GSK's RSV vaccine in this at increased risk population

[jubberjim] 22/11/2024 08:26

Have added more just now.

It is my opinion that the reason the economy is in such dire straits is primarily because our esteemed fund managers are a complete and utter bunch of nimrods.

This is a buy but wtfdIk

[supermarky] 21/11/2024 08:23

1820 to 1300 wow!At what point is the doom and gloom priced in? Obviously sentiment is low but as we all should know.... things can quickly turn. I am holding firm and just topped up earlier this week. There are always 2 sides to a coin

[washingmachine] 20/11/2024 19:18

Target 600 pence !

[chachacha] 20/11/2024 18:20

Not a good sector to be invested in at the moment.Another class action initiated. This time against J&J.Never ending gravy train for greedy lawyers.

[ricardo montalban] 20/11/2024 10:47

Next stop 12 quid.

[supermarky] 20/11/2024 10:46

Yep I didn't bet the house on it. Just topped up as this level seems attractive and good support. Oversold imo but who knows. Buy and hold.

[rikky72] 20/11/2024 08:59

This is GSK; he only has coal for us..

[geckotheglorious] 19/11/2024 19:56

Supermarky

Must be close to the lows surely.
Tempted but I'm going to sit tight until the new year personally..
unless there are some serious gyrations over the incoming December low liquidity period.

[supermarky] 19/11/2024 15:55

I bought a few more a few hours ago at 12.98.Major support here Let's see how this rolls.

[tradermichael] 19/11/2024 15:17

Good news today re. successful Phase lll Linerixibat results.

There's another 23 Phase lll candidates in the pipeline, many of which are very important medicines, with indications:

Urogenital gonorrhoea (GC)
Chronic hepatitis B virus infection
COPD
2L Non-small cell lung cancer combination with Jemperli (dostarlimab) and docetaxel
Prevention of invasive disease caused by N. meninigitidis serogroup B in individuals 2 months of age and older (US)
Frontotemporal dementia (FTD) due to heterozygous mutations in the progranulin gene
Asthma
Complicated urinary tract infection (cUTI)
Invasive candidiasis

.... and others.

The 'market' has to acknowledge these breakthroughs soon .... ;0)

[jubberjim] 19/11/2024 15:15

Gecko

I will qualify the remark just for you

'two short'

Satisfied

[jubberjim] 19/11/2024 11:17

Are you trying to initiate a war here Gecko ??

Plank!